| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology, University of Geneva, Geneva, Switzerland
We explored the role of CD40-CD40L (CD154) in the severe malaria elicited by Plasmodium berghei anka infection in mice. Mortality was >90% by day 8 after infection in +/+ mice, but markedly decreased in CD40-/- or in CD40L-/- mice, as well as in +/+ mice treated with anti-CD40L monoclonal antibody. Parasitemia was similar in the different conditions. Breakdown of the blood-brain barrier was evident in infected +/+, but not in CD40-/- mice. Thrombocytopenia was less severe in CD40-/- mice than in the +/+ controls. Sequestration of macrophages in brain venules and alveolar capillaries was reduced in CD40-/- or in CD40L-/- mice, whereas sequestration of parasitized red blood cells or polymorphonuclear leukocytes in alveolar capillaries was CD40-CD40L-independent. CD40 mRNA was increased in the brain and lung of infected mice whereas CD40L was increased in the lung. Tumor necrosis factor plasma levels were similarly increased in infected +/+ or CD40-/- mice. Expression of CD54 and its mRNA levels in the brain were moderately decreased in CD40-deficient mice. Thus the mortality associated with severe malaria requires CD40-CD40L interaction that contributes to the breakdown of the blood-brain barrier, macrophage sequestration, and platelet consumption.
This article has been cited by other articles:
 |
|
 |
|
  I. Gramaglia, H. Sahlin, J. P. Nolan, J. A. Frangos, M. Intaglietta, and H. C. van der Heyde Cell- Rather Than Antibody-Mediated Immunity Leads to the Development of Profound Thrombocytopenia during Experimental Plasmodium berghei Malaria J. Immunol., December 1, 2005; 175(11): 7699 - 7707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Leisewitz, K. A. Rockett, B. Gumede, M. Jones, B. Urban, and D. P. Kwiatkowski Response of the Splenic Dendritic Cell Population to Malaria Infection Infect. Immun., July 1, 2004; 72(7): 4233 - 4239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. S. Prasad, P. Andre, M. He, M. Bao, J. Manganello, and D. R. Phillips Soluble CD40 ligand induces {beta}3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling PNAS, October 14, 2003; 100(21): 12367 - 12371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Gold, M. Parsey, Y. Hoshino, S. Hoshino, A. Nolan, H. Yee, D. B. Tse, and M. D. Weiden CD40 Contributes to Lethality in Acute Sepsis: In Vivo Role for CD40 in Innate Immunity Infect. Immun., June 1, 2003; 71(6): 3521 - 3528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Angulo and M. Fresno Cytokines in the Pathogenesis of and Protection against Malaria Clin. Vaccine Immunol., November 1, 2002; 9(6): 1145 - 1152. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Barazzone Argiroffo, Y. R. Donati, J. Boccard, A. F. Rochat, C. Vesin, C.-D. Kan, and P.-F. Piguet CD40-CD40 Ligand Disruption Does Not Prevent Hyperoxia-Induced Injury Am. J. Pathol., January 1, 2002; 160(1): 67 - 71. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
